- Home
- CATO vs FORA Comparison
CATO vs FORA Comparison
Compare CATO & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CATO | FORA |
|---|---|---|
| Founded | 1946 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.5M | 69.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CATO | FORA |
|---|---|---|
| Price | $3.48 | $2.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 54.5K | 35.5K |
| Earning Date | 11-20-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $660,062,000.00 | $28,106,911.00 |
| Revenue This Year | N/A | $47.82 |
| Revenue Next Year | N/A | $10.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 37.47 |
| 52 Week Low | $2.19 | $1.64 |
| 52 Week High | $4.92 | $4.03 |
Technical Indicators
Market Signals| Indicator | CATO | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 44.76 |
| Support Level | $3.13 | $2.11 |
| Resistance Level | $3.60 | $2.20 |
| Average True Range (ATR) | 0.19 | 0.07 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 73.68 | 46.05 |
Price Performance
Historical ComparisonAbout CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.